235 related articles for article (PubMed ID: 26496968)
21. [A case of pneumonia caused by Mycobacterium avium complex successfully treated with clarithromycin].
Hamada H; Kohno N; Yokoyama A; Kondo K; Hiwada K
Nihon Ronen Igakkai Zasshi; 2000 Sep; 37(9):749-53. PubMed ID: 11109848
[TBL] [Abstract][Full Text] [Related]
22. [Clinical study on development of nontuberculous mycobacterial lung disease].
Kurashima A
Kekkaku; 2004 Dec; 79(12):737-41. PubMed ID: 15782619
[TBL] [Abstract][Full Text] [Related]
23. Mycobacterium Avium complex vertebral osteomyelitis in the absence of HIV infection: a case report and review.
Gray ME; Liu PW; Wispelwey B
BMC Infect Dis; 2018 May; 18(1):235. PubMed ID: 29788907
[TBL] [Abstract][Full Text] [Related]
24. Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Kim SY; Koh WJ; Park HY; Jeon K; Kwon OJ; Cho SN; Shin SJ
Clin Exp Immunol; 2014 Apr; 176(1):93-101. PubMed ID: 24354934
[TBL] [Abstract][Full Text] [Related]
25. Analysis of chest CT in patients with Mycobacterium avium complex pulmonary disease.
Fujiuchi S; Matsumoto H; Yamazaki Y; Nakao S; Takahashi M; Satoh K; Takeda A; Okamoto K; Fujita Y; Fujikane T; Shimizu T
Respiration; 2003; 70(1):76-81. PubMed ID: 12584395
[TBL] [Abstract][Full Text] [Related]
26. Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
Chen LF; Mo YQ; Jing J; Ma JD; Zheng DH; Dai L
Int J Rheum Dis; 2017 Jul; 20(7):859-869. PubMed ID: 28160426
[TBL] [Abstract][Full Text] [Related]
27. Safety of subcutaneous versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
McLaughlin M; Östör A
Expert Opin Drug Saf; 2015 Mar; 14(3):429-37. PubMed ID: 25553607
[TBL] [Abstract][Full Text] [Related]
28. A Novel Approach to Extensive Clarithromycin-Resistant Mycobacterium avium Complex Pulmonary Disease.
Togo T; Atsumi J; Hiramatsu M; Shimoda K; Morimoto K; Shiraishi Y
Ann Thorac Cardiovasc Surg; 2022 Dec; 28(6):444-447. PubMed ID: 33967121
[TBL] [Abstract][Full Text] [Related]
29. Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host.
O'Beirne SL; Escalon JG; Momtahen S; Hissong E; Port JL; Schenck EJ; Legasto AC; Kaner RJ
Am J Respir Crit Care Med; 2015 Dec; 192(11):1387-8. PubMed ID: 26244303
[No Abstract] [Full Text] [Related]
30. Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy.
Song SN; Yoshizaki K
Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):307-16. PubMed ID: 25491492
[TBL] [Abstract][Full Text] [Related]
31. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary Mycobacterium szulgai infection and treatment in a patient receiving anti-tumor necrosis factor therapy.
van Ingen J; Boeree M; Janssen M; Ullmann E; de Lange W; de Haas P; Dekhuijzen R; van Soolingen D
Nat Clin Pract Rheumatol; 2007 Jul; 3(7):414-9. PubMed ID: 17599076
[TBL] [Abstract][Full Text] [Related]
33. [A patient with Mycobacterium avium lung disease presenting with rapid, progressive and multiple cavity formation, who had been treated rheumatoid arthritis with disease modifying anti-rheumatic drugs (DMARDs)].
Uruga H; Izumi S; Hojo M; Sugiyama H; Toyota E; Kobayashi N; Kudo K
Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):195-201. PubMed ID: 18409565
[TBL] [Abstract][Full Text] [Related]
34. Serum interleukin 6 before and after therapy with tocilizumab is a principal biomarker in patients with rheumatoid arthritis.
Shimamoto K; Ito T; Ozaki Y; Amuro H; Tanaka A; Nishizawa T; Son Y; Inaba M; Nomura S
J Rheumatol; 2013 Jul; 40(7):1074-81. PubMed ID: 23637318
[TBL] [Abstract][Full Text] [Related]
35. Tocilizumab efficacy and safety in rheumatoid arthritis patients after inadequate response to disease-modifying anti-rheumatic drugs oranti-tumor necrosis factor.
Abdulkader OAF; Qushmaq K; Aljishi F
Ann Saudi Med; 2016; 36(3):190-6. PubMed ID: 27236390
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary nocardiosis caused by Nocardia cyriacigeorgica in patients with Mycobacterium avium complex lung disease: two case reports.
Yagi K; Ishii M; Namkoong H; Asami T; Fujiwara H; Nishimura T; Saito F; Kimizuka Y; Asakura T; Suzuki S; Kamo T; Tasaka S; Gonoi T; Kamei K; Betsuyaku T; Hasegawa N
BMC Infect Dis; 2014 Dec; 14():684. PubMed ID: 25491030
[TBL] [Abstract][Full Text] [Related]
37. Impact of rifampicin on the pharmacokinetics of clarithromycin and 14-hydroxy clarithromycin in patients with multidrug combination therapy for pulmonary Mycobacterium avium complex infection.
Iketani O; Komeya A; Enoki Y; Taguchi K; Uno S; Uwamino Y; Matsumoto K; Kizu J; Hasegawa N
J Infect Chemother; 2022 Jan; 28(1):61-66. PubMed ID: 34706852
[TBL] [Abstract][Full Text] [Related]
38. [Tocilizumab in rheumatoid arthritis].
Rueda Gotor J; Blanco Alonso R
Reumatol Clin; 2011 Mar; 6S3():S29-32. PubMed ID: 21794769
[TBL] [Abstract][Full Text] [Related]
39. The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab: retreatment of patients with rheumatoid arthritis with novel anti-IL-6 receptor antibody after a long-term interval following SAMURAI: the RONIN study.
Sagawa A
Mod Rheumatol; 2011 Aug; 21(4):352-8. PubMed ID: 21347804
[TBL] [Abstract][Full Text] [Related]
40. Cavitary pulmonary disease in a patient treated with natalizumab.
de Masson A; Maillart E; Veziris N; Meyssonnier V; Papeix C; Caumes E
Presse Med; 2014 Sep; 43(9):1009-12. PubMed ID: 24742610
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
